We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$21.7M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$13.8M
3
SPLV icon
Invesco S&P 500 Low Volatility ETF
SPLV
+$12.8M
4
USO icon
United States Oil Fund
USO
+$12.5M
5
IBB icon
iShares Biotechnology ETF
IBB
+$12M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSWC icon
3501
Capital Southwest
CSWC
$1.59B
$25.9K ﹤0.01%
1,093
-793
-42% -$17.7K
PLYA
3502
DELISTED
Playa Hotels & Resorts
PLYA
$25.7K ﹤0.01%
2,973
-9,112
-75% -$68.6K
ATXS
3503
DELISTED
Astria Therapeutics
ATXS
$25.7K ﹤0.01%
3,346
-11
-0.3% -$61
GBDC icon
3504
Golub Capital BDC
GBDC
$3.45B
$25.6K ﹤0.01%
1,696
-1,043
-38% -$15.3K
CKPT
3505
DELISTED
Checkpoint Therapeutics
CKPT
$25.6K ﹤0.01%
11,174
+5,375
+93% +$11.7K
BCSF icon
3506
Bain Capital Specialty
BCSF
$804M
$25.5K ﹤0.01%
1,695
-2,948
-63% -$44.9K
HUMA icon
3507
Humacyte
HUMA
$164M
$25.5K ﹤0.01%
8,989
+6,504
+262% +$16.7K
IJK icon
3508
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.3B
$25.5K ﹤0.01%
322
-8,637
-96% -$634K
VMD icon
3509
Viemed Healthcare
VMD
$352M
$25.5K ﹤0.01%
3,249
+1,191
+58% +$8.64K
WB icon
3510
Weibo
WB
$1.87B
$25.4K ﹤0.01%
2,322
-6,034
-72% -$68.5K
LUNR icon
3511
Intuitive Machines
LUNR
$3.1B
$25.4K ﹤0.01%
9,945
-33,661
-77% -$104K
URGN icon
3512
UroGen Pharma
URGN
$2.33B
$25.4K ﹤0.01%
1,691
-8,699
-84% -$113K
DRD
3513
DRDGold
DRD
$2.09B
$25.3K ﹤0.01%
3,180
+3,179
+317,900% +$27.3K
ALRS icon
3514
Alerus Financial
ALRS
$838M
$25.3K ﹤0.01%
1,129
+261
+30% +$4.93K
DNTH icon
3515
Dianthus Therapeutics
DNTH
$6.47B
$25.3K ﹤0.01%
+2,430
New +$26.8K
QQQS icon
3516
Invesco NASDAQ Future Gen 200 ETF
QQQS
$22.9M
$25.2K ﹤0.01%
959
-3,335
-78% -$75.8K
KNTE
3517
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$25.2K ﹤0.01%
10,636
-70
-0.7% -$124
SEZL
3518
Sezzle
SEZL
$4.49B
$25.1K ﹤0.01%
+7,338
New +$14.6K
TIGO icon
3519
Millicom
TIGO
$15.6B
$25.1K ﹤0.01%
1,394
+1,303
+1,432% +$21.3K
POL
3520
DELISTED
Polished.com Inc.
POL
$25K ﹤0.01%
4,145
+4,136
+45,956% +$10.2K
VTNR
3521
DELISTED
Vertex Energy, Inc
VTNR
$25K ﹤0.01%
7,367
-265
-3% -$1.04K
EXAI
3522
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$24.9K ﹤0.01%
3,882
-1,926
-33% -$10.9K
ACWX icon
3523
iShares MSCI ACWI ex US ETF
ACWX
$12B
$24.9K ﹤0.01%
487
-732
-60% -$35.2K
PLBC icon
3524
Plumas Bancorp
PLBC
$435M
$24.9K ﹤0.01%
601
+241
+67% +$8.7K
COYA icon
3525
Coya Therapeutics
COYA
$112M
$24.8K ﹤0.01%
3,344
+1,243
+59% +$6.9K
139 140
141
142 143

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.